Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: J Hypertens. 2016 Oct;34(10):2008–2025. doi: 10.1097/HJH.0000000000001029

FIGURE 4.

FIGURE 4

Plasma angiotensin 1–7 levels (a), plasma angiotensin-converting enzyme type 2 activity (b) and the ratio of plasma angiotensin-1–7 to angiotensin II in indole-3-carbinol induced and noninduced Cyp1a1-Ren-2 transgenic rats. Effects of epoxyeicosatrienoic acid analog and angiotensin-converting enzyme inhibition treatment. *P < 0.05 versus noninduced rats. #P < 0.05 versus *marked values. @P < 0.05 versus untreated indole-3-carbinol induced rats.